Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.18% | 7.20% | 4.94% | 2.97% | 0.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.18% | 7.20% | 4.94% | 2.98% | 0.18% |
| Cost of Revenue | 7.24% | 9.46% | 4.28% | 3.99% | -0.11% |
| Gross Profit | 4.66% | 4.13% | 5.90% | 1.54% | 0.62% |
| SG&A Expenses | 3.59% | 2.71% | 1.15% | -2.30% | -4.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -550.00% | -- | -- | -- |
| Total Operating Expenses | 6.01% | 5.43% | 3.36% | 2.41% | -1.11% |
| Operating Income | 7.01% | 14.32% | 12.13% | 5.67% | 6.67% |
| Income Before Tax | 7.47% | 7.55% | 5.73% | 1.72% | -0.43% |
| Income Tax Expenses | -26.32% | 2.00% | 109.09% | -28.13% | -66.19% |
| Earnings from Continuing Operations | 9.60% | 8.00% | -0.55% | 4.18% | 13.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.00% | -200.00% | -- | 66.67% | 0.00% |
| Net Income | 9.56% | 7.32% | -0.86% | 4.46% | 13.48% |
| EBIT | 7.01% | 14.32% | 12.13% | 5.67% | 6.67% |
| EBITDA | 6.21% | 10.32% | 5.75% | 0.00% | -0.62% |
| EPS Basic | 11.32% | 9.03% | 0.19% | 5.56% | 14.68% |
| Normalized Basic EPS | 7.65% | 11.86% | 13.08% | 9.00% | 4.90% |
| EPS Diluted | 11.31% | 9.28% | 0.47% | 5.89% | 15.03% |
| Normalized Diluted EPS | 7.65% | 11.86% | 13.67% | 9.28% | 5.17% |
| Average Basic Shares Outstanding | -1.59% | -1.57% | -1.05% | -1.05% | -1.05% |
| Average Diluted Shares Outstanding | -1.58% | -1.57% | -1.56% | -1.31% | -1.30% |
| Dividend Per Share | 9.30% | 10.26% | 10.26% | 10.26% | 10.26% |
| Payout Ratio | -0.01% | 0.01% | 0.10% | 0.04% | -0.03% |